Literature DB >> 27278608

Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?

André O von Bueren1,2, Clemens Seidel3, Carsten Friedrich3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27278608     DOI： 10.1007/s11060-016-2159-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

1.  Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.

Authors:  André O von Bueren; Carsten Friedrich; Katja von Hoff; Robert Kwiecien; Klaus Müller; Torsten Pietsch; Monika Warmuth-Metz; Peter Hau; Martin Benesch; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Eur J Cancer       Date:  2015-08-05       Impact factor: 9.162

2.  Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?

Authors:  E Franceschi; M Bartolotti; A Paccapelo; G Marucci; R Agati; L Volpin; D Danieli; C Ghimenton; M P Gardiman; C Sturiale; R Poggi; M Mascarin; D Balestrini; B Masotto; A A Brandes
Journal:  J Neurooncol       Date:  2016-03-03       Impact factor: 4.130

3.  Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Peter Hau; Frank Deinlein; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Eur J Cancer       Date:  2012-11-19       Impact factor: 9.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.